Novavax "Can Produce Omicron Vaccine Next Month"
American pharmaceutical company Novavax announced that it will be able to produce a vaccine targeting the new COVID-19 variant Omicron starting next month.
According to major foreign media on the 2nd (local time), Novavax stated regarding the commercial production of the Omicron-specific vaccine, "We have begun developing the Omicron-specific spike protein antigen and will start laboratory testing of the new vaccine within a few weeks."
Novavax is also experimenting with a 'two-track' strategy to determine whether the existing COVID-19 vaccine is effective against the Omicron variant.
Novavax had previously announced on the 26th of last month (local time) that it had started developing a vaccine for the Omicron variant.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- "It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
Other vaccine manufacturers such as Moderna and Pfizer-BioNTech have also begun developing vaccines to respond to the Omicron variant.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
